Literature DB >> 23295884

Severity of atopic dermatitis and Ascaris lumbricoides infection: an evaluation of CCR4+ and CXCR3+ helper T cell frequency.

Maria Teresa Nascimento Silva1, Vlaudia Assis Costa, Teobaldo Gonzaga Realço Pereira, Iana Rafaela Fernandes Sales, Silvana Ferreira da Silva, Maria Amélia Vieira Maciel, Elizabeth Malagueño, Valdênia Maria Oliveira Souza.   

Abstract

INTRODUCTION: Ascaris lumbricoides-infected patients present lower prevalence of severe atopic dermatitis.
METHODS: Peripheral blood of infected children with atopic dermatitis was assessed by flow cytometry of the frequency of Th1 and Th2 cells through the expression of CXCR3 and CCR4 chemokine receptors, respectively.
RESULTS: Helminth-free patients with atopic dermatitis presented a high frequency of CCR4+Th2 cells. Parasitized patients with atopic dermatitis showed a lower frequency of CXCR3+Th1 cells compared to infected individuals only.
CONCLUSIONS: Ascariasis modifies the blood traffic of Th2 cells in atopic dermatitis patients, while the allergic disease down-regulates the traffic of Th1 cells in parasitized patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23295884     DOI: 10.1590/s0037-86822012000600021

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  Interleukin-10 and soil-transmitted helminth infections in Honduran children.

Authors:  Ana Lourdes Sanchez; Dylan Lewis Mahoney; José Antonio Gabrie
Journal:  BMC Res Notes       Date:  2015-02-25

Review 2.  The exposome in atopic dermatitis.

Authors:  Nicholas Stefanovic; Carsten Flohr; Alan D Irvine
Journal:  Allergy       Date:  2019-08-19       Impact factor: 13.146

3.  Identification and Physicochemical Characterization of a New Allergen from Ascaris lumbricoides.

Authors:  Velky Ahumada; María Manotas; Josefina Zakzuk; Lorenz Aglas; Sandra Coronado; Peter Briza; Peter Lackner; Ronald Regino; Galber Araujo; Fatima Ferreira; Luis Caraballo
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.